Innovative Therapeutic Approaches in Hepatocellular Carcinoma Drugs

Hepatocellular carcinoma (HCC) represents the most common type of primary liver cancer and poses significant challenges globally due to its late diagnosis and limited treatment options. The evolving landscape of HCC drugs reflects the urgent need for...